PAYER POLICY CHANGES

A9555 Insurance Policy Changes

HCPCS A9555 is officially defined as "Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries." HCPCS A9555 is referenced in 3 tracked payer policy changes from Excellus BlueCross BlueShield, Blue Cross & Blue Shield of Mississippi, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A9555 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch A9555

Get one email when a payer policy names A9555, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for A9555

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for A9555 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.